Answer
Vizimpro (dacomitinib monohydrate) is contraindicated in anyone with hypersensitivity to its active substance or any excipient listed in section 6.1.
Sources for this answer
- Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked